Search results
Showing: 10 of 392
Drug Tariff News - March Part VIIIA reimbursement prices
The Department of Health has agreed that the March Drug Tariff Part VIIIA reimbursement price for the following items will be:
Amitriptyline 50mg tablets £3.50
Dapsone 50mg tablets £46.19
Exemestane 25mg tablets £12.60
Flecainide 100mg tablets…
ePACT2: Changes to Actual Cost reporting calculation (Pharmacy only)
The prescription data reports have been updated to reflect the recent changes to the discount deduction applied to pharmacy contractors' monthly total of reimbursement prices, as listed in the Drug Tariff Part V.
From April 2024, any financial…
Oversupply dashboard
The comparators in this dashboard have been developed in response to the National Overprescribing Review (NOR). They relate to the quality of the prescribing system in addressing or avoiding overprescribing.
Specifically, the comparators relate to…
Important information on drug data
The ‘One Drug Database’ project is underway, which will move all of our drug data into one place. This will provide a consistent, single source of information.
For years, we’ve had two sources of drug data – Master Data Replacement (MDR) for…
ePACT2 user agreement (EUA)
This ePACT2 User Agreement (EUA) is a legal agreement between you (either an individual or a single entity) and the NHS Business Services Authority (NHSBSA).
NHSBSA grants you the right to access the NHSBSA’s online system, ePACT2, which includes…
National medicines optimisation opportunities
The national medicines optimisation opportunities dashboard has been developed with NHS England to bring together data to support the national medicines optimisation opportunities 2024/25. It includes metrics to support 12 of the opportunity areas…
Requesting our ophthalmic data
If you require access to a specific set of Ophthalmic data this can be requested in different ways. This page details the options available and provides more information on the process involved in each.
Academic Research requests (patient…